NCAPD3
Condensin-2 complex subunit D3
Also known as: CAP-D3, CNDD3_HUMAN, FLJ42888, hCAP-D3, hcp-6, hHCP-6, KIAA0056
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P42695
- Gene
- NCAPD3
- Ensembl
- ENSG00000151503
- Chromosome
- 11
- Canonical length
- 1498 aa
- Protein class
- Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm
OverviewNCBI Gene
Condensin complexes I and II play essential roles in mitotic chromosome assembly and segregation. Both condensins contain 2 invariant structural maintenance of chromosome (SMC) subunits, SMC2 (MIM 605576) and SMC4 (MIM 605575), but they contain different sets of non-SMC subunits. NCAPD3 is 1 of 3 non-SMC subunits that define condensin II (Ono et al., 2003 [PubMed 14532007]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
1498 residues, UniProt reviewed canonical sequence.
>P42695|NCAPD3
1 MVALRGLGSG LQPWCPLDLR LEWVDTVWEL DFTETEPLDP SIEAEIIETG LAAFTKLYES
61 LLPFATGEHG SMESIWTFFI ENNVSHSTLV ALFYHFVQIV HKKNVSVQYR EYGLHAAGLY
121 FLLLEVPGSV ANQVFHPVMF DKCIQTLKKS WPQESNLNRK RKKEQPKSSQ ANPGRHRKRG
181 KPPRREDIEM DEIIEEQEDE NICFSARDLS QIRNAIFHLL KNFLRLLPKF SLKEKPQCVQ
241 NCIEVFVSLT NFEPVLHECH VTQARALNQA KYIPELAYYG LYLLCSPIHG EGDKVISCVF
301 HQMLSVILML EVGEGSHRAP LAVTSQVINC RNQAVQFISA LVDELKESIF PVVRILLQHI
361 CAKVVDKSEY RTFAAQSLVQ LLSKLPCGEY AMFIAWLYKY SRSSKIPHRV FTLDVVLALL
421 ELPEREVDNT LSLEHQKFLK HKFLVQEIMF DRCLDKAPTV RSKALSSFAH CLELTVTSAS
481 ESILELLINS PTFSVIESHP GTLLRNSSAF SYQRQTSNRS EPSGEINIDS SGETVGSGER
541 CVMAMLRRRI RDEKTNVRKS ALQVLVSILK HCDVSGMKED LWILQDQCRD PAVSVRKQAL
601 QSLTELLMAQ PRCVQIQKAW LRGVVPVVMD CESTVQEKAL EFLDQLLLQN IRHHSHFHSG
661 DDSQVLAWAL LTLLTTESQE LSRYLNKAFH IWSKKEKFSP TFINNVISHT GTEHSAPAWM
721 LLSKIAGSSP RLDYSRIIQS WEKISSQQNP NSNTLGHILC VIGHIAKHLP KSTRDKVTDA
781 VKCKLNGFQW SLEVISSAVD ALQRLCRASA ETPAEEQELL TQVCGDVLST CEHRLSNIVL
841 KENGTGNMDE DLLVKYIFTL GDIAQLCPAR VEKRIFLLIQ SVLASSADAD HSPSSQGSSE
901 APASQPPPQV RGSVMPSVIR AHAIITLGKL CLQHEDLAKK SIPALVRELE VCEDVAVRNN
961 VIIVMCDLCI RYTIMVDKYI PNISMCLKDS DPFIRKQTLI LLTNLLQEEF VKWKGSLFFR
1021 FVSTLIDSHP DIASFGEFCL AHLLLKRNPV MFFQHFIECI FHFNNYEKHE KYNKFPQSER
1081 EKRLFSLKGK SNKERRMKIY KFLLEHFTDE QRFNITSKIC LSILACFADG ILPLDLDASE
1141 LLSDTFEVLS SKEIKLLAMR SKPDKDLLME EDDMALANVV MQEAQKKLIS QVQKRNFIEN
1201 IIPIIISLKT VLEKNKIPAL RELMHYLREV MQDYRDELKD FFAVDKQLAS ELEYDMKKYQ
1261 EQLVQEQELA KHADVAGTAG GAEVAPVAQV ALCLETVPVP AGQENPAMSP AVSQPCTPRA
1321 SAGHVAVSSP TPETGPLQRL LPKARPMSLS TIAILNSVKK AVESKSRHRS RSLGVLPFTL
1381 NSGSPEKTCS QVSSYSLEQE SNGEIEHVTK RAISTPEKSI SDVTFGAGVS YIGTPRTPSS
1441 AKEKIEGRSQ GNDILCLSLP DKPPPQPQQW NVRSPARNKD TPACSRRSLR KTPLKTANLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NCAPD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 53 nTPM
Expression across tissuesHPA
Tissue
- prostate: 53 nTPM
- thymus: 17 nTPM
- tonsil: 7.3 nTPM
- thyroid gland: 6.2 nTPM
- lymph node: 5.3 nTPM
- appendix: 5.2 nTPM
Single-cell type
- erythrocyte progenitors: 146 nCPM
- cardiomyocytes: 110 nCPM
- monocyte progenitors: 100 nCPM
- sertoli cells: 99 nCPM
- megakaryocyte progenitors: 92 nCPM
- corticotrophs: 78 nCPM
Immune cell
- T-reg: 3.2 nTPM
- naive CD8 T-cell: 3.1 nTPM
- NK-cell: 2.8 nTPM
- gdT-cell: 2.5 nTPM
- plasmacytoid DC: 2.5 nTPM
- naive CD4 T-cell: 2.4 nTPM
Brain region
- cerebral cortex: 8.8 nTPM
- white matter: 8.8 nTPM
- cerebellum: 7.7 nTPM
- basal ganglia: 7.1 nTPM
- thalamus: 7 nTPM
- hippocampal formation: 6.7 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NCAPD3.
Disease | AllUniProt
Conditions NCAPD3 is implicated in, by any mechanism.
- Microcephaly 22, primary, autosomal recessive (MCPH22) MIM:617984
Disease | GeneticClinVar
11 pathogenic / likely-pathogenic of 387 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Microcephaly 22, primary, autosomal recessive
- See cases
- NCAPD3-related disorder
Disease | ImmuneIEDB
Conditions an epitope on NCAPD3 was assayed in.
- systemic scleroderma B cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.73
- DepMap mean gene effect
- -0.81
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cell division
- meiotic chromosome condensation
- mitotic chromosome condensation
- positive regulation of chromosome condensation
- positive regulation of chromosome segregation
- positive regulation of chromosome separation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NCAPD3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NCAPD3 as an antibody target. Whether an autoantibody or antibody against NCAPD3 could matter depends on whether native NCAPD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NCAPD3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NCAPD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...